NeuroTransit Overview
- Year Founded
-
2008

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
NeuroTransit General Information
Description
Owner and operator of a bio pharmaceutical company intended to offer therapeutics for neurologic, metabolic and oncologic diseases. The company bio pharmaceutical services include using proprietary technology for the development of drug products that cross the blood-brain barrier, enabling patients to avail treatment for neurologic, metabolic and oncologic diseases of the brain.
Contact Information
Website
www.neurotransit.comCorporate Office
- 6020 Cornerstone West Court
- Suite 200
- San Diego, CA 92121
- United States
Corporate Office
- 6020 Cornerstone West Court
- Suite 200
- San Diego, CA 92121
- United States
NeuroTransit Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Feb-2018 | Completed | Out of Business | |||
1. Early Stage VC | 01-Jan-2013 | Completed | Startup |
NeuroTransit FAQs
-
When was NeuroTransit founded?
NeuroTransit was founded in 2008.
-
Where is NeuroTransit headquartered?
NeuroTransit is headquartered in San Diego, CA.
-
What industry is NeuroTransit in?
NeuroTransit’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is NeuroTransit a private or public company?
NeuroTransit is a Private company.
-
What is NeuroTransit’s current revenue?
The current revenue for NeuroTransit is
.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »